PREMARIN DHES COMPONENT "EXTREMELY UNLIKELY" TO ADD TO EFFICACY, SAYS UMASS' LONGCOPE IN COMMENTS FOR BARR; FDA MEETING WILL HEAR GENERIC COMMENTS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".